Skip to main content
. 2025 Jun 11;17(12):1945. doi: 10.3390/cancers17121945
CAR chimeric antigen receptor
FDA Food and Drug Administration
GMP good manufacturing practice
HLA human leukocyte antigen
IL interleukin
iPSC induced pluripotent stem cell
MHC major histocompatibility complex
NK natural killer
TCR T-cell receptor
TME tumor microenvironment
WIPO World Intellectual Property Organization